menu ☰
menu ˟

Genomic test identified men at high risk for prostate cancer recurrence

25 Apr 2014
Researchers in Canada have developed a genomic test to identify patients with prostate cancer who are at high risk for recurrence after surgery or radiotherapy, according to findings presented at the European Society for Radiotherapy and Oncology.“...

Click here to view the full article which appeared in Hematology Oncology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.